InsiderChief Executive Officer

Serge Saxonov Insider Trading Activity

Every SEC Form 4 transaction reported by Serge Saxonov, sourced directly from SEC EDGAR and updated as new filings are accepted.

Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Is Serge Saxonov buying or selling?

Serge Saxonov reported 0 open-market buys ($0) and 68 sells ($55.5M) across 68 Form 4 filings at 1 company — a net selling position of $55.5M.

Source: SEC EDGAR Form 4

What stands out

  • All 68 of Serge Saxonov's Form 4 filings are for one company, 10x Genomics, Inc. (TXG).
  • The most recent Form 4 was accepted on Sep 24, 2026 (24 days ago).
  • In the last 12 months: no open-market purchases and 10 sales ($6.8M).
  • The largest open-market sale in the last 12 months was $2.0M of 10x Genomics, Inc. (TXG) on Sep 24, 2026. SEC ↗

Key Statistics (as of Sep 24, 2026)

Total Form 4 filings
68
SEC EDGAR
Companies
1
Buys (0)
$0
Sells (68)
$55.5M

Insider sentiment

Net selling

Net insider flow of $55.5M in net selling, filed between Mar 10, 2020 – Sep 24, 2026.

Companies Serge Saxonov files for

#CompanyForm 4 filings
1TXG10x Genomics, Inc.68

Recent Serge Saxonov transactions

DateTickerRoleTypeSharesValueFiling
Sep 24, 2026TXGChief Executive OfficerSale25.0K$2.0MSEC ↗
Aug 28, 2026TXGChief Executive OfficerSale10.5K$667.9KSEC ↗
Aug 26, 2026TXGChief Executive OfficerSale18.5K$1.2MSEC ↗
Jun 24, 2026TXGChief Executive OfficerSale30.0K$1.0MSEC ↗
May 27, 2026TXGChief Executive OfficerSale28.9K$709.1KSEC ↗
Apr 16, 2026TXGChief Executive OfficerSale5.0K$122.8KSEC ↗
Mar 25, 2026TXGChief Executive OfficerSale15.0K$288.9KSEC ↗
Mar 4, 2026TXGChief Executive OfficerSale16.2K$367.1KSEC ↗
Feb 25, 2026TXGChief Executive OfficerSale9.6K$178.9KSEC ↗
Nov 25, 2025TXGChief Executive OfficerSale13.3K$251.9KSEC ↗
Aug 26, 2025TXGChief Executive OfficerSale9.3K$128.9KSEC ↗
May 27, 2025TXGChief Executive OfficerSale9.3K$77.5KSEC ↗
Mar 4, 2025TXGChief Executive OfficerSale7.9K$84.4KSEC ↗
Feb 26, 2025TXGChief Executive OfficerSale5.1K$56.3KSEC ↗
Nov 25, 2024TXGChief Executive OfficerSale6.7K$91.6KSEC ↗
Aug 26, 2024TXGChief Executive OfficerSale6.7K$152.1KSEC ↗
May 23, 2024TXGChief Executive OfficerSale4.9K$118.5KSEC ↗
Mar 6, 2024TXGChief Executive OfficerSale4.7K$205.0KSEC ↗
Feb 26, 2024TXGChief Executive OfficerSale2.8K$130.7KSEC ↗
Feb 20, 2024TXGChief Executive OfficerSale5.0K$244.3KSEC ↗
Feb 13, 2024TXGChief Executive OfficerSale1.0K$49.5KSEC ↗
Jan 18, 2024TXGChief Executive OfficerSale4.0K$181.0KSEC ↗
Dec 18, 2023TXGChief Executive OfficerSale2.0K$110.1KSEC ↗
Nov 27, 2023TXGChief Executive OfficerSale7.5K$325.6KSEC ↗
Nov 16, 2023TXGChief Executive OfficerSale2.0K$79.0KSEC ↗

Showing the 25 most recent filings of 68. Screen every filing.

Serge Saxonov insider trading FAQ

Is Serge Saxonov buying or selling?

Across 68 SEC Form 4 filings, Serge Saxonov reported 0 open-market purchases totaling $0 and 68 sales totaling $55.5M — a net selling position of $55.5M.

Which companies does Serge Saxonov file Form 4s for?

Serge Saxonov has reported insider transactions at 1 company, most often 10x Genomics, Inc. (TXG).

How far back does Serge Saxonov's filing history go?

Trabud holds Serge Saxonov's SEC Form 4 filings from Mar 10, 2020 – Sep 24, 2026, sourced directly from SEC EDGAR.

Where does Trabud get Serge Saxonov's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Track Serge Saxonov and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener